Establishment Labs Holdings Debt to Equity Ratio 2017-2023 | ESTA
Current and historical debt to equity ratio values for Establishment Labs Holdings (ESTA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Establishment Labs Holdings debt/equity for the three months ending December 31, 2023 was 10.26.
| Establishment Labs Holdings Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-12-31 | $0.25B | $0.02B | 13.60 |
| 2023-09-30 | $0.24B | $0.03B | 7.87 |
| 2023-06-30 | $0.23B | $0.06B | 4.20 |
| 2023-03-31 | $0.23B | $-0.02B | -14.09 |
| 2022-12-31 | $0.22B | $-0.01B | -26.79 |
| 2022-09-30 | $0.19B | $0.00B | 122.54 |
| 2022-06-30 | $0.18B | $0.02B | 11.60 |
| 2022-03-31 | $0.09B | $0.05B | 1.96 |
| 2021-12-31 | $0.09B | $0.05B | 1.75 |
| 2021-09-30 | $0.09B | $0.06B | 1.41 |
| 2021-06-30 | $0.08B | $0.07B | 1.21 |
| 2021-03-31 | $0.08B | $0.07B | 1.10 |
| 2020-12-31 | $0.08B | $0.08B | 1.09 |
| 2020-09-30 | $0.08B | $0.08B | 0.94 |
| 2020-06-30 | $0.08B | $0.08B | 0.92 |
| 2020-03-31 | $0.08B | $0.09B | 0.87 |
| 2019-12-31 | $0.08B | $0.04B | 1.94 |
| 2019-09-30 | $0.07B | $0.04B | 1.70 |
| 2019-06-30 | $0.05B | $0.05B | 0.95 |
| 2019-03-31 | $0.05B | $0.06B | 0.79 |
| 2018-12-31 | $0.05B | $0.07B | 0.68 |
| 2018-09-30 | $0.04B | $0.08B | 0.58 |
| 2018-06-30 | $0.06B | $0.00B | 25.71 |
| 2018-03-31 | $0.07B | $-0.01B | -7.74 |
| 2017-12-31 | $0.06B | $-0.01B | -12.39 |
| 2017-09-30 | $0.00B | $0.00B | 0.00 |
| 2017-06-30 | $0.00B | $0.00B | 0.00 |
| 2017-03-31 | $0.00B | $0.00B | 0.00 |
| 2016-12-31 | $0.06B | $-0.03B | -2.12 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.493B | $0.165B |
| Establishment Labs Holdings Inc. is a medical technology company. It focuses on designing, developing, manufacturing and marketing portfolio of silicone gel-filled breast implants ae well as body shaping implants. The company's brand consists of Motiva Implants(R) and MotivaImagine (R) platform. Its technologies portfolio includes Divina 3D Simulation System(R), Puregraft and MotivaImagine Centers (R). Establishment Labs Holdings Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $123.165B | 15.45 |
| Cencora (COR) | United States | $44.692B | 17.42 |
| ICON (ICLR) | Ireland | $25.998B | 24.54 |
| DiDi Global (DIDIY) | China | $24.302B | 0.00 |
| Avantor (AVTR) | United States | $16.893B | 24.87 |
| CochLear (CHEOY) | Australia | $14.118B | 0.00 |
| Viatris (VTRS) | United States | $14.074B | 4.05 |
| Revvity (RVTY) | United States | $12.701B | 22.25 |
| Medpace Holdings (MEDP) | United States | $12.416B | 40.85 |
| Charles River Laboratories (CRL) | United States | $12.119B | 22.09 |
| Natera (NTRA) | United States | $11.739B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.436B | 0.00 |
| Solventum (SOLV) | United States | $11.160B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.373B | 0.00 |
| HealthEquity (HQY) | United States | $6.801B | 50.81 |
| Organon (OGN) | United States | $5.318B | 5.04 |
| Bausch + Lomb (BLCO) | Canada | $5.074B | 20.34 |
| Doximity (DOCS) | United States | $4.589B | 34.17 |
| PACS (PACS) | United States | $3.743B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.254B | 30.12 |
| Sotera Health (SHC) | United States | $3.196B | 15.68 |
| Progyny (PGNY) | United States | $3.114B | 52.26 |
| GoodRx Holdings (GDRX) | United States | $2.951B | 149.40 |
| Life Times (LTH) | United States | $2.907B | 30.79 |
| Premier (PINC) | United States | $2.483B | 9.09 |
| AMN Healthcare Services Inc (AMN) | United States | $2.270B | 7.34 |
| Teladoc Health (TDOC) | United States | $2.169B | 0.00 |
| Agilon Health (AGL) | United States | $1.985B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.955B | 0.00 |
| NovoCure (NVCR) | Jersey | $1.673B | 0.00 |
| Agiliti (AGTI) | United States | $1.368B | 22.33 |
| Alignment Healthcare (ALHC) | United States | $1.296B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.780B | 8.07 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Embecta (EMBC) | United States | $0.598B | 3.95 |
| InnovAge Holding (INNV) | United States | $0.587B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.533B | 0.00 |
| CareDx (CDNA) | United States | $0.527B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.510B | 0.00 |
| LifeMD (LFMD) | United States | $0.509B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.497B | 0.00 |
| Enhabit (EHAB) | United States | $0.495B | 44.82 |
| Sonida Senior Living (SNDA) | United States | $0.449B | 0.00 |
| MultiPlan (MPLN) | United States | $0.429B | 0.00 |
| Beauty Health (SKIN) | United States | $0.423B | 0.00 |
| DocGo (DCGO) | United States | $0.385B | 61.67 |
| ModivCare (MODV) | United States | $0.381B | 7.12 |
| Sera Prognostics (SERA) | United States | $0.322B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.267B | 0.00 |
| Sharecare (SHCR) | United States | $0.261B | 0.00 |
| Biodesix (BDSX) | United States | $0.174B | 0.00 |
| So-Young (SY) | China | $0.128B | 43.00 |
| Oncology Institute (TOI) | United States | $0.070B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.069B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
| NeueHealth (NEUE) | United States | $0.051B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.033B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| OncoCyte (OCX) | United States | $0.023B | 0.00 |
| DermTech (DMTK) | United States | $0.022B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |